David Cunningham
0000-0001-5158-1069
Royal Marsden NHS Foundation Trust
652 papers found
Refreshing results…
A Golden Conundrum
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy
Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma
Targeting Vascular Endothelial Growth Factor in Oesophagogastric Cancer: A Review of Progress to Date and Immunotherapy Combination Strategies
Analysis of KRAS , NRAS , BRAF , PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients
Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro‐oesophageal junction
Panitumumab Alone for Maintenance Treatment in Advanced Colorectal Cancer
Abstract 2646: Proteomic approaches to study cetuximab resistance inRAS/BRAFwild type colorectal cancer
Differences in Signaling Patterns on PI3K Inhibition Reveal Context Specificity in KRAS-Mutant Cancers
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer
Identification of a nanostring signature that differentiates early pancreatic cancers according to stromal composition and predicts clinical outcome
Treatment of relapsed oesophagogastric adenocarcinoma after perioperative chemotherapy and surgery
The use of first, second and beyond line chemotherapy for metastatic pancreatic ductal adenocarcinoma at the Royal Marsden Hospital
Florid T follicular helper cell hyperplasia associated with extranodal marginal zone lymphoma: a diagnostic pitfall which may mimic T cell lymphoma
Safety and Efficacy of the Pd-L1 Inhibitor Durvalumab With R-Chop or R2 -Chop in Subjects With Previously Untreated, High-Risk Dlbcl
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Detecting and Tracking Circulating Tumour DNA Copy Number Profiles during First Line Chemotherapy in Oesophagogastric Adenocarcinoma
Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes
International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis
Missing publications? Search for publications with a matching author name.